CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Surge in global burden of viral infection
3.3.1.2.Stronger pipeline of anti-viral drugs
3.3.2.Restraints
3.3.2.1.Higher cost of treatment
3.3.3.Opportunities
3.3.3.1.Increase in number of product approvals for combination therapy
CHAPTER 4:ANTI-VIRAL THERAPIES MARKET, BY APPLICATION
4.1.Overview
4.1.1.Market size and forecast
4.2.HIV
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Hepatitis
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Herpes virus
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Influenza
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Other Applications
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:ANTI-VIRAL THERAPIES MARKET, BY TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Generic drugs
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Branded drugs
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:ANTI-VIRAL THERAPIES MARKET, BY MECHANISM OF ACTION
6.1.Overview
6.1.1.Market size and forecast
6.2.Nucleotide polymerase inhibitor
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Reverse transcriptase inhibitors
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Protease inhibitors
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
6.5.Others
6.5.1.Market size and forecast, by region
6.5.2.Market analysis, by country
CHAPTER 7:GLOBAL ANTI-VIRAL THERAPIES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by type
7.2.3.Market size and forecast, by mechanism of action
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by type
7.2.5.2.U.S. Market size and forecast, by mechanism of action
7.2.5.3.U.S. market size and forecast, by application
7.2.5.4.Canada market size and forecast, by type
7.2.5.5.Canada Market size and forecast, by mechanism of action
7.2.5.6.Canada market size and forecast, by application
7.2.5.7.Mexico market size and forecast, by type
7.2.5.8.Mexico Market size and forecast, by mechanism of action
7.2.5.9.Mexico market size and forecast, by application
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by type
7.3.3.Market size and forecast, by mechanism of action
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.5.1.Germany market size and forecast, by type
7.3.5.2.Germany Market size and forecast, by mechanism of action
7.3.5.3.Germany market size and forecast, by application
7.3.5.4.France market size and forecast, by type
7.3.5.5.France Market size and forecast, by mechanism of action
7.3.5.6.France market size and forecast, by application
7.3.5.7.UK market size and forecast, by type
7.3.5.8.UK Market size and forecast, by mechanism of action
7.3.5.9.UK market size and forecast, by application
7.3.5.10.Italy market size and forecast, by type
7.3.5.11.Italy Market size and forecast, by mechanism of action
7.3.5.12.Italy market size and forecast, by application
7.3.5.13.Spain market size and forecast, by type
7.3.5.14.Spain Market size and forecast, by mechanism of action
7.3.5.15.Spain market size and forecast, by application
7.3.5.16.Rest of Europe market size and forecast, by type
7.3.5.17.Rest of Europe Market size and forecast, by mechanism of action
7.3.5.18.Rest of Europe market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by type
7.4.3.Market size and forecast, by mechanism of action
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country
7.4.5.1.Japan market size and forecast, by type
7.4.5.2.Japan Market size and forecast, by mechanism of action
7.4.5.3.Japan market size and forecast, by application
7.4.5.4.China market size and forecast, by type
7.4.5.5.China Market size and forecast, by mechanism of action
7.4.5.6.China market size and forecast, by application
7.4.5.7.India market size and forecast, by type
7.4.5.8.India Market size and forecast, by mechanism of action
7.4.5.9.India market size and forecast, by application
7.4.5.10.Australia market size and forecast, by type
7.4.5.11.Australia Market size and forecast, by mechanism of action
7.4.5.12.Australia market size and forecast, by application
7.4.5.13.South Korea market size and forecast, by type
7.4.5.14.South Korea Market size and forecast, by mechanism of action
7.4.5.15.South Korea market size and forecast, by application
7.4.5.16.Rest of Asia-Pacific market size and forecast, by type
7.4.5.17.Rest of Asia-Pacific Market size and forecast, by mechanism of action
7.4.5.18.Rest of Asia-Pacific market size and forecast, by application
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by type
7.5.3.Market size and forecast, by mechanism of action
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil market size and forecast, by type
7.5.5.2.Brazil Market size and forecast, by mechanism of action
7.5.5.3.Brazil market size and forecast, by application
7.5.5.4.Saudi market size and forecast, by type
7.5.5.5.Saudi Market size and forecast, by mechanism of action
7.5.5.6.Saudi market size and forecast, by application
7.5.5.7.South Africa market size and forecast, by type
7.5.5.8.South Africa Market size and forecast, by mechanism of action
7.5.5.9.South Africa market size and forecast, by application
7.5.5.10.Rest of LAMEA market size and forecast, by type
7.5.5.11.Rest of LAMEA Market size and forecast, by mechanism of action
7.5.5.12.Rest of LAMEA market size and forecast, by application
CHAPTER 8:COMPANY PROFILES
8.1.Abbott Laboratories
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.AbbVie Inc.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance
8.2.5.Key strategic moves and developments
8.3.Bristol Myers Squibb Company
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.F. Hoffmann-La Roche Ltd.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.Johnson & Johnson
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Business performance
8.6.Merck & Co., Inc.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Business performance
8.6.5.Key strategic moves and developments
8.7.GILEAD SCIENCES, INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.GlaxoSmithKline Plc.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.AstraZeneca PLC
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.Aurobindo Pharma Limited
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
